| Literature DB >> 36011613 |
Min Gyun Kim1,2, Seung Ah Lee1, Eo Jin Park1, Min Kyu Choi1, Ji Min Kim1, Min Kyun Sohn3, Sung Ju Jee3, Yeong Wook Kim4, Jung Eun Son1, Seo Jun Lee1, Keum Sun Hwang1, Seung Don Yoo1,5.
Abstract
BACKGROUND: Shoulder subluxation occurs in 17-64% of hemiplegic patients after stroke and develops mostly during the first three weeks of hemiplegia. A range of shoulder orthoses has been used in rehabilitation to prevent subluxation. However, there is little evidence of their efficacy. AIM: This study aimed to investigate whether there is a difference in the subluxation distance, pain, and functional level of the hemiplegic upper extremity among patients with two different shoulder orthoses.Entities:
Keywords: hemiplegia; infarction; orthoses; rehabilitation; shoulder pain; shoulder subluxation; stroke
Mesh:
Year: 2022 PMID: 36011613 PMCID: PMC9408021 DOI: 10.3390/ijerph19169975
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Elastic dynamic shoulder sling.
Figure 2Bobath sling.
Figure 3Timeline of assessment and follow up of enrolled participants.
Figure 4Measurement of horizontal distances (HD) and vertical distances (VD) in a true anteroposterior radiograph.
Figure 5Flow chart of study participants enrollment.
Baseline characteristics of the elastic dynamic sling group and the Bobath sling group (mean ± standard deviations).
| Characteristics | Elastic Dynamic Sling Group | Bobath Sling Group | |
|---|---|---|---|
| Age (years) | 64.76 ± 12.80 | 63.60 ± 14.46 | 0.774 |
| Sex (male) | 13 | 10 | 0.443 |
| K-MBI | 35.00 ± 17.85 | 30.90 ± 20.50 | 0.267 |
| FMA-total | 9.86 ± 9.94 | 8.10 ± 7.08 | 0.579 |
| MMT (of shoulder) | 1.44 ± 0.92 | 1.27 ± 0.76 | 0.413 |
| Underlying disease | |||
| HTN | 81.0% ( | 65.0% ( | 0.247 |
| DM | 28.6% ( | 30.0% ( | 0.920 |
| Dyslipidemia | 14.3% ( | 25.0% ( | 0.387 |
| Lesion | |||
| Brain stem | 4.76% ( | 5% ( | 0.972 |
| Non-brain stem | 95.24% ( | 95% ( | |
| Stroke | |||
| Infarction | 71.43% ( | 55% ( | 0.275 |
| Hemorrhage | 28.57% ( | 45% ( |
K-MBI, Korean-modified Barthel index; MMT, manual muscle testing; FMA, Fugl-Meyer assessment; HTN, hypertension; DM, diabetes mellitus.
Difference of vertical distance between the elastic dynamic sling group and the Bobath sling group.
| Average | |||
|---|---|---|---|
| Elastic Dynamic Sling Group | Bobath Sling Group | ||
| VD0 | 42.99 ± 8.41 | 41.44 ± 9.06 | |
| VD1 | 43.66 ± 8.26 | 44.57 ± 7.16 | |
| VD2 | 45.60 ± 9.05 | 42.87 ± 9.16 | |
| ∆VD1 | 0.67 ± 7.76 | 3.05 ± 9.00 | 0.382 |
| ∆VD2 | 2.61 ± 10.95 | 1.43 ± 12.58 | 0.751 |
VD: vertical distance; D0: initial distance without sling; D1: 4 weeks after using sling; D2: 8 weeks after using sling; ∆VD1: difference between D0 and D1; ∆VD2: difference between D0 and D2; independent-samples t-test for between-group comparison.
Difference in horizontal distance between the elastic dynamic sling group and the Bobath sling group.
| Average | |||
|---|---|---|---|
| Elastic Dynamic Sling Group | Bobath Sling Group | ||
| HD0 | 28.02 ± 2.66 | 27.44 ± 2.16 | |
| HD1 | 27.13 ± 2.21 | 28.14 ± 2.52 | |
| HD2 | 27.22 ± 2.40 | 29.73 ± 4.08 | |
| ∆HD1 | −0.89 ± 2.46 | 0.48 ± 2.32 | 0.083 |
| ∆HD2 | −0.80 ± 3.11 | 2.28 ± 3.66 |
|
Independent-samples t-test for between-group comparisons; HD: horizontal distance; D0: initial distance without sling; D1: 4 weeks after using sling; D2: 8 weeks after using sling; ∆HD1: difference between D0 and D1; ∆HD2: difference between D0 and D2.
Comparison of vertical and horizontal distances within the groups at four and eight weeks.
| Measure | Baseline | 4 Weeks | 8 Weeks | ||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | |||
| Elastic Dynamic Sling Group | |||||
| Vertical Distance | 42.99 ± 8.41 | 43.66 ± 8.26 | 45.60 ± 9.05 | 0.7355 a | 0.193 a |
| Horizontal Distance | 28.02 ± 2.66 | 27.13 ± 2.21 | 27.22 ± 2.40 | 0.584 a | 0.3309 a |
| Bobath Group | |||||
| Vertical Distance | 41.44 ± 9.06 | 44.57 ± 7.16 | 42.87 ± 9.16 | 0.1666 a | 0.4203 a |
| Horizontal Distance | 27.44 ± 2.16 | 28.14 ± 2.52 | 29.73 ± 4.08 |
|
|
Analysis was based on intention to treat. Values are presented as the average ± standard deviation. a Linear mixed model for within-group comparison; p1, comparison between baseline and four weeks; p2, comparison between baseline and 8 weeks.
Comparison of VAS, FMA-UE, MBI, MAS, and MMT within the groups at four and eight weeks.
| Measure | Baseline | 4 Weeks | 8 Weeks | ||
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | |||
| Elastic Dynamic Sling Group | |||||
| FMA-UE | 7.52 ± 5.62 | 12.24 ± 7.45 | 15.25 ± 8.81 |
|
|
| FMA-Wrist | 1.05 ± 1.94 | 2.05 ± 3.26 | 2.26 ± 4.06 | 0.0691 a |
|
| FMA-Hand | 1.14 ± 3.09 | 1.81 ± 2.89 | 2.85 ± 4.32 | 0.1081 a |
|
| FMA-Co | 0.14 ± 0.65 | 0.33 ± 1.06 | 1.45 ± 2.39 | 0.6379 a |
|
| FMA-Total | 10.05 ± 9.77 | 15.48 ± 13.28 | 22.15 ± 17.10 |
|
|
| MBI | 35.00 ± 17.85 | 46.00 ± 17.98 | 58.80 ± 27.73 |
|
|
| Pain (VAS) | 1.52 ± 2.14 | 1.76 ± 2.47 | 1.86 ± 2.46 | 0.6332 a | 0.5046 a |
| MAS | 0.33 ± 0.58 | 0.67 ± 0.70 | 0.76 ± 0.87 |
|
|
| MMT | 1.55 ± 0.95 | 2.71 ± 1.88 | 3.19 ± 1.97 |
|
|
| Bobath Group | |||||
| FMA-UE | 6.70 ± 5.14 | 14.53 ± 8.52 | 16.65 ± 9.39 |
|
|
| FMA-Wrist | 0.90 ± 2.10 | 2.26 ± 3.23 | 2.85 ± 3.38 |
|
|
| FMA-Hand | 0.20 ± 0.62 | 2.58 ± 3.58 | 3.95 ± 4.87 |
|
|
| FMA-Co | 0.30 ± 0.73 | 1.00 ± 1.73 | 1.00 ± 1.75 | 0.0522 a |
|
| FMA-Total | 8.10 ± 7.08 | 20.11 ± 14.91 | 24.60 ± 17.16 |
|
|
| MBI | 30.90 ± 20.50 | 44.70 ± 22.75 | 51.30 ± 27.18 |
|
|
| Pain (VAS) | 1.35 ± 2.64 | 1.20 ± 1.82 | 1.70 ± 2.60 | 0.7717 a | 0.4994 a |
| MAS | 0.25 ± 0.53 | 0.48 ± 0.55 | 0.65 ± 0.90 | 0.1840 a |
|
| MMT | 1.35 ± 0.88 | 3.08 ± 1.66 | 3.35 ± 2.30 |
|
|
Analysis was based on intention to treat. Values were presented as the average ± standard deviation. a Linear mixed model for within-group comparison; p1, comparison between baseline and four weeks; p2, comparison between baseline and 8 weeks; FMA, Fugl-Meyer assessment scale; FMA-UE, upper extremity; FMA-Co, cooperation, MBI, modified Barthel index; MAS, modified Ashworth scale; VAS, visual analogue scale.
Comparison of VAS, FMA-UE, MBI, MAS, and MMT between groups at four and eight weeks.
| Average | |||
|---|---|---|---|
| Elastic Dynamic Sling Group | Bobath Sling Group | ||
| 4 weeks | |||
| ∆FMA-UE1 | 4.71 ± 4.66 | 7.68 ± 9.40 | 0.448 |
| ∆FMA-Wrist1 | 1.00 ± 2.17 | 1.32 ± 2.00 | 0.437 |
| ∆FMA-Hand1 | 0.67 ± 1.35 | 2.37 ± 3.48 | 0.063 |
| ∆FMA-Co1 | 0.19 ± 0.87 | 0.68 ± 1.63 | 0.146 |
| ∆FMA-Total1 | 5.43 ± 7.63 | 11.79 ± 15.06 | 0.125 |
| ∆MBI1 | 11.00 ± 12.32 | 13.80 ± 16.41 | 0.887 |
| ∆Pain (VAS)1 | 0.24 ± 2.21 | −0.15 ± 1.79 | 0.908 |
| ∆MAS1 | 0.33 ± 0.86 | 0.23 ± 0.47 | 0.621 |
| ∆MMT1 | 1.17 ± 1.37 | 0.40 ± 0.94 | 0.246 |
| 8 weeks | |||
| ∆FMA-UE2 | 7.55 ± 6.71 | 9.95 ± 9.74 | 0.467 |
| ∆FMA-Wrist2 | 1.65 ± 3.25 | 1.95 ± 2.19 | 0.532 |
| ∆FMA-Hand2 | 1.65 ± 2.41 | 3.75 ± 4.84 | 0.329 |
| ∆FMA-Co2 | 1.30 ± 2.39 | 0.70 ± 1.53 | 0.585 |
| ∆FMA-Total2 | 11.80 ± 11.65 | 16.50 ± 16.20 | 0.377 |
| ∆MBI2 | 22.75 ± 17.27 | 20.40 ± 20.51 | 0.601 |
| ∆Pain (VAS)2 | 0.33 ± 2.61 | 0.35 ± 3.05 | 0.999 |
| ∆MAS2 | 0.43 ± 0.76 | 0.40 ± 0.94 | 0.839 |
| ∆MMT2 | 1.64 ± 1.41 | 2.00 ± 2.34 | 0.752 |
Analysis was based on intention to treat. Values were presented as the average ± standard deviation. Independent-samples t-test for between-group comparison; FMA, Fugl-Meyer assessment scale; FMA-UE, upper extremity; FMA-Co, cooperation, MBI, modified Barthel index; MAS, modified Ashworth scale; VAS, visual analogue scale.